AFWM
KRYS icon

Abich Financial Wealth Management’s Krystal Biotech KRYS Stock Holding History

Abich Financial Wealth Management’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$69.7K Buy
+395
New +$59.1K 0.02% 268
2024
Q3 		– Sell
-14
Closed -$2.57K – 653
2024
Q2 		$2.57K Buy
14
+4
+40% +$672 ﹤0.01% 439
2024
Q1 		$1.78K Buy
+10
New +$1.39K ﹤0.01% 381

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Abich Financial Wealth Management's KRYS Position: Q3 2025 in Review

Abich Financial Wealth Management opened a new position in Krystal Biotech (KRYS) in Q3 2025: 395 shares worth $69.7K. The stake represents 0.02% of the portfolio and ranks #268 among its holdings. This is a return to the name: Abich Financial Wealth Management previously reported a position in KRYS as recently as Q2 2024.

Abich Financial Wealth Management first reported a position in KRYS in Q1 2024 and has held it in 3 quarters since. 284 funds tracked by Wall St. Rank hold KRYS as of Q3 2025.

  • Abich Financial Wealth Management held 395 shares of Krystal Biotech worth $69.7K as of Q3 2025.
  • Krystal Biotech was a new Abich Financial Wealth Management position in Q3 2025.
  • Krystal Biotech made up 0.02% of Abich Financial Wealth Management's portfolio in Q3 2025, its #268 holding.
  • Abich Financial Wealth Management first reported a position in Krystal Biotech in Q1 2024 and has held it in 3 quarters since.
  • 284 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2025.

Based on Abich Financial Wealth Management's 13F filing for Q3 2025, filed 6 Nov 2025.